[ACE-inhibitor effects on the stabilization of coronary heart disease. EUROPA study].
Böhm
M
M
Klinik für Innere Medizin III, Universitätsklinikum, Homburg/Saar. boehm@med-in.uni-saarland.de
D000293:Adolescent; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002423:Cause of Death; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006323:Heart Arrest / Q000209:etiology / Q000517:prevention & control; D006333:Heart Failure / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control; D020913:Perindopril / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D020913:Perindopril
ACE-Hemmer bei stabiler koronarer Herzerkrankung. EUROPA-Studie.